Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Sep 1, 2023
- Accession no.
- 0001447362-23-000134
- Filed
- Sep 1, 2023
- Trade date
- Aug 30-31, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 14 non-derivative transactions. Open-market sales total $239.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 30, 2023 | Common Stock | SSaleDisposed | −1,622 | $20.03F2 | −$32,488.66 | 119,905 | Direct | |
| Aug 30, 2023 | Common Stock | SSaleDisposed | −512 | $20.03F2 | −$10,255.36 | 107,368 | Indirect | |
| Aug 30, 2023 | Common Stock | SSaleDisposed | −512 | $20.03F2 | −$10,255.36 | 96,263 | Indirect | |
| Aug 30, 2023 | Common Stock | SSaleDisposed | −187 | $20.03F2 | −$3,745.61 | 17,208 | Indirect | |
| Aug 30, 2023 | Common Stock | SSaleDisposed | −189 | $20.03F2 | −$3,785.67 | 17,208 | Indirect | |
| Aug 30, 2023 | Common Stock | SSaleDisposed | −189 | $20.03F2 | −$3,785.67 | 17,208 | Indirect | |
| Aug 30, 2023 | Common Stock | SSaleDisposed | −189 | $20.03F2 | −$3,785.67 | 17,202 | Indirect | |
| Aug 31, 2023 | Common Stock | SSaleDisposed | −4,084 | $20.06F9 | −$81,925.04 | 115,821 | Direct | |
| Aug 31, 2023 | Common Stock | SSaleDisposed | −1,289 | $20.06F9 | −$25,857.34 | 106,079 | Indirect | |
| Aug 31, 2023 | Common Stock | SSaleDisposed | −1,289 | $20.06F9 | −$25,857.34 | 94,974 | Indirect | |
| Aug 31, 2023 | Common Stock | SSaleDisposed | −474 | $20.06F9 | −$9,508.44 | 16,734 | Indirect | |
| Aug 31, 2023 | Common Stock | SSaleDisposed | −473 | $20.06F9 | −$9,488.38 | 16,735 | Indirect | |
| Aug 31, 2023 | Common Stock | SSaleDisposed | −473 | $20.06F9 | −$9,488.38 | 16,735 | Indirect | |
| Aug 31, 2023 | Common Stock | SSaleDisposed | −473 | $20.06F9 | −$9,488.38 | 16,729 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $20.000 to $20.065, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $22.000 to $20.295, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.